Akeso Announces First Patient Dosed in Phase I Trial of Personalized mRNA Vaccine AK154 as Monotherapy or in Combination with Cadonilimab or Ivonescimab for Adjuvant Treatment of Pancreatic Cancer

HONG KONG, Nov. 10, 2025 /PRNewswire/ — Akeso, Inc. (HKEX: 9926. HK)…

DFRobot UNIHIKER K10 Crowned Winner in Teach Secondary's EdTech & Software Category at 2025 TeachCo Resource Awards

SHANGHAI, Nov. 10, 2025 /PRNewswire/ — DFRobot is proud to announce that its…

CNFINANCE TO HOLD AN EXTRAORDINARY GENERAL MEETING ON DECEMBER 10, 2025

GUANGZHOU, China, Nov. 10, 2025 /PRNewswire/ — CNFinance Holdings Limited (NYSE: CNF)…

Bybit Adds Polkadot (DOT) to On-Chain Earn

DUBAI, UAE, Nov. 10, 2025 /PRNewswire/ — Bybit, the world’s second-largest cryptocurrency…

AION UT Officially Launched in Macao, GAC Deeply Implements 'Macao ACTION' to Accelerate Ecological Globalization

MACAO, Nov. 10, 2025 /PRNewswire/ — From November 7th to 9th, The…

2025 Taiwan Design Expo "(((Changhua)))" Closes with Record-Breaking Scale and Attendance, Unveiling a New Changhua Transformed by Design

TAIPEI, Nov. 10, 2025 /PRNewswire/ — Held annually across different locales and…

Tuya to Report Third Quarter 2025 Financial Results on November 24, 2025 Eastern Time

SANTA CLARA, Calif., Nov. 10, 2025 /PRNewswire/ — Tuya Inc. ("Tuya" or…

Yatsen to Announce Third Quarter 2025 Financial Results on November 17, 2025

GUANGZHOU, China, Nov. 10, 2025 /PRNewswire/ — Yatsen Holding Limited ("Yatsen" or…